INTRODUCTION
============

G protein-coupled receptors (GPCRs) are classified into rhodopsin-like, secretin-like, and metabotropic glutamate-like families based on the size and shape of their N-terminal region ([@b4-bt-24-517]). Rhodopsin-like GPCRs are further classified into subfamilies, which bind to different ligands including catecholamines, peptides, and glycoprotein hormones. Dopamine D~2~ and D~3~ receptors (D~2~R and D~3~R, respectively) belong to the catecholamine subfamily and are important targets for the treatment of various diseases associated with motor, emotional, and endocrine dysfunction ([@b19-bt-24-517]; [@b7-bt-24-517]).

GPCRs including D~2~R and D~3~R contain relatively well-conserved transmembrane regions, but the sizes and amino acid sequences of the N-termini and intracellular loops are variable ([@b7-bt-24-517]). According to the crystal structure of D~3~R ([@b5-bt-24-517]), the three-dimensional structure around the TM domains was clearly defined, and the ionic interactions among the well-conserved amino acid residues of the TM regions and adjacent submolecular domains were well predicted. However, the structural features of the other re gions, especially those of the N-terminal region could not be determined.

Upon stimulation by agonists, GPCRs activate G proteins and are phosphorylated by G protein-coupled receptor kinases (GRKs). In response to agonistic stimulation, some GPCRs undergo GRK2/3-mediated phosphorylation and interact with β-arrestins, which results in desensitization of the GPCRs, and this was exemplified by β~2~ adrenergic receptor (β~2~AR) ([@b12-bt-24-517]; [@b13-bt-24-517]). When exposed to agonists for extended periods, GPCRs are endocytosed in a complex with β-arrestin ([@b9-bt-24-517]; [@b10-bt-24-517]), and may or may not dissociate from the co-internalized β-arrestins after entering the cells. Based on the postendocytic behaviors of GPCRs with β-arrestins, GPCRs are classified as either class A or class B ([@b14-bt-24-517]).

Recent studies have suggested that β-arrestins mediate G protein-independent atypical signaling, and evidence for this was mainly demonstrated by ERK activation ([@b1-bt-24-517]; [@b2-bt-24-517]). It remains unclear how β-arrestins mediate various cellular processes such as desensitization, endocytosis, and atypical signaling. As an initial step toward understanding the multifaceted roles of β-arrestins in these processes, we determined the roles of distinct GPCR subregions in the interactions with β-arrestins.

MATERIALS AND METHODS
=====================

Materials
---------

Human embryonic kidney 293 (HEK-293) cells were purchased from American Type Culture Collection (Manassas, VA, USA). HEK-293 cells were cultured in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific, Waltham, MA USA), 100 units/ml penicillin and 100 μg/ml streptomycin in a humidified atmosphere containing 5% CO~2~. The cells were transfected using polyethyleneimine (PEI) (Warrington, PA, USA). \[^3^H\]-spiperone was purchased from PerkinElmer Life Sciences (Boston, MA, USA). Dopamine (DA), antibodies to Flag, and anti-M2 Flag antibody-conjugated agarose beads were obtained from Sigma/Aldrich Chemical Co. (St. Louis, MO, USA). Antibodies to β-arrestin were kindly provided by Dr. Lefkowitz (Duke University, NC, USA).

Plasmid constructs
------------------

The human genes encoding for D~2~R and D~3~R in the pCMV5 vector, either untagged or tagged with Flag epitopes at the N-termini, were described elsewhere ([@b11-bt-24-517]; [@b8-bt-24-517]). D~2~R and D~3~R chimeric receptors, in which the second and third intracellular loops or N/C-termini were exchanged, were described previously ([@b18-bt-24-517]; [@b20-bt-24-517]), or prepared by site-directed mutagenesis. Specifically, in D~2~R-(IL2/3-D~3~R), the second and third intracellular loops of D~2~R were exchanged with those of D~3~R. In D~3~R-(IL2/3-D~2~R), the second and third intracellular loops of D~3~R were exchanged with those of D~2~R. D~2~R mutants lacking either the N-terminus or C-terminus were prepared by site-directed mutagenesis.

Immunoprecipitation
-------------------

Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 1% NP-40, 0.5% deoxycholate, 0.1% SDS) on a rotation wheel for 1 h at 4°C. The supernatant was mixed with 35 μL of 50% slurry of anti-Flag antibody-conjugated agarose beads for 2--3 h on the rotation wheel. The beads were washed with washing buffer (50 mM Tris, pH 7.4, 137 mM NaCl, 10% glycerol, 1% NP-40) three times for 10 min each.

Confocal microscopy
-------------------

For β-arrestin translocation assays, HEK-293 cells were transfected with β-arrestin2-GFP and corresponding GPCRs ([@b11-bt-24-517]). One day after transfection, cells were seeded onto 35-mm dishes containing a centered, 1-cm well and allowed to recover for 1 day. Cells were then incubated with 2 mL MEM containing 20 mM HEPES (pH 7.4) and viewed on a Zeiss laser scanning confocal microscope.

RESULTS
=======

D~2~R but not D~3~R mediates agonist-induced β-arrestin translocation
---------------------------------------------------------------------

Upon binding to agonists, GPCRs undergo conformational changes resulting in signaling and a series of regulatory processes. For example, Gβγ helps recruit GPCR kinase2/3 (GRK2/3) from the cytosol to the plasma membrane to phosphorylate activated receptors ([@b16-bt-24-517]). Phosphorylated receptors exhibit a higher affinity to β-arrestin, causing translocation of β-arrestins from the cytosol to the extracellular membrane ([@b3-bt-24-517]). Translocated β-arrestins bind to agonist-occupied GPCRs to which they exert multiple effects such as desensitization and receptor endocytosis. Thus, agonist-induced translocation of β-arrestins is a biomarker to predict the uncoupling of the receptors from G proteins and GPCR endocytosis.

As shown in [Fig. 1A](#f1-bt-24-517){ref-type="fig"}, agonist stimulation of D~2~R but not D~3~R resulted in β-arrestin2 translocation, suggesting that these two receptors could be used to determine the particular regions involved in β-arrestin2 translocation. The second and third intracellular loops are the main regions involved in GPCR interactions with various proteins including G proteins ([@b17-bt-24-517]). To test whether the second and third loops are involved in the agonist-induced β-arrestin2 translocation, six different D~2~R and D~3~R chimeric receptors were prepared ([Fig. 1B](#f1-bt-24-517){ref-type="fig"}). For each chimeric receptor, either the second or third intracellular loop or both loops were replaced with those of the other receptor.

The second and third intracellular loops are both involved in agonist-induced translocation of β-arrestin2
----------------------------------------------------------------------------------------------------------

To understand the roles of the intracellular loops of D~2~R in β-arrestin2 translocation, chimeras of D~2~R and D~3~R were utilized. The first loop was excluded because point mutations in serine and threonine residues located within the first loop did not affect D~2~R endocytosis, which is a direct downstream event of β-arrestin translocation ([@b6-bt-24-517]). As shown in [Fig. 2](#f2-bt-24-517){ref-type="fig"}, D~2~R clearly mediated the translocation of β-arrestin2, whereas D~3~R failed to accomplish this (second and sixth images). As the second or third loop of D~2~R was replaced with that of D~3~R, D~2~R showed a decreased ability to recruit β-arrestin2 (third and fourth images) and failed to recruit β-arrestin2 when both loops were replaced (fifth image). In the reverse situation, D~3~R gained the ability to translocate β-arrestin2, as the second or third intracellular loop was replaced with that of D~2~R (seventh and eighth images), and the functional phenotype of D~3~R was changed to that of D~2~R when both loops were exchanged (ninth image). However, it should be noted that D~2~R clearly retained the ability to translocate β-arrestin2 when the second or third intracellular loop was replaced with that of D~3~R, while D~3~R could not, as clearly, gain the ability to translocate β-arrestin2 when both loops were replaced with those of D~2~R. Thus, it could be concluded that the second and third intracellular loops of D~2~R play central roles in the translocation of β-arrestin2, though other subregions also possess certain roles.

Constitutive interactions are controlled by the N- or C-terminus
----------------------------------------------------------------

The roles of the N-terminus of D~2~R or D~3~R in the interaction with β-arrestins have not been reported. The N-terminus of D~2~R consists of 37 amino acids and contains three N-linked glycosylation sites (N-X-S/T) ([Fig. 3A](#f3-bt-24-517){ref-type="fig"}). Since N-linked glycosylation is important in the surface expression of certain GP-CRs, we prepared three constructs in which approximately 10 consecutive amino acids were deleted. For example, Δ(2--10) represents a deletion mutant of D~2~R in which the amino acids 2 through 10 were deleted. Surface expression of Δ(2--34) was too seriously impaired (data not shown), and thus could not be used for functional studies. As shown in [Fig. 3B](#f3-bt-24-517){ref-type="fig"}, agonist stimulation of D~2~R resulted in an increase in the interaction between D~2~R and β-arrestin2. However, deletion of 21 amino acid residues located within the N-terminus of D~2~R, Δ(2--22), resulted in a marked increase in the basal interaction with β-arrestin2.

When the carboxyl tails of D~2~R and D~3~R are compared, it becomes apparent that D~2~R contains four extra residues near the seventh transmembrane domain. Other than this difference, the only difference found between the two C-termini was one amino acid residue that precedes the cysteine residue, which is the last amino acid residue of each receptor ([Fig. 4A](#f4-bt-24-517){ref-type="fig"}). Replacement of the C-terminus of D~2~R with that of D~3~R (D~2~R-D~3~C) did not affect the pattern of the interaction with β-arrestin2, that is, the interaction was increased in response to treatment with the agonist ([Fig. 4B](#f4-bt-24-517){ref-type="fig"}). Conversely, deletion of the C-terminus of D~2~R (CTX-D~2~R) inhibited the receptor expression levels, but also markedly increased the basal interaction with β-arrestin2 ([Fig. 4C](#f4-bt-24-517){ref-type="fig"}).

DISCUSSION
==========

Like other GPCRs, D~2~R and D~3~R contain the characteristic topology of heptahelical receptors: N-terminus, seven trans-membrane (TM) domains, three extracellular and intracellular loops, and C-terminal tail. Although the TM regions are relatively well-conserved among GPCRs, most GPCRs including D~2~R and D~3~R, differ in their amino acid sequences and in the lengths of their N-terminal region, intracellular loops, and C-terminal tail ([@b7-bt-24-517]).

The roles of the intracellular loops and C-terminal tails of some GPCRs have been extensively characterized in terms of G-protein coupling and intracellular trafficking ([@b15-bt-24-517]; [@b7-bt-24-517]). However, both D~2~R and D~3~R have relatively short C-terminal tails, consisting of fourteen and ten amino acid residues, respectively; thus, it was difficult to study functional roles of the C-termini of D~2~R and D~3~R. It is unlikely that the C-terminal tail of D~2~R plays a major role in determining the interaction with β-arrestin2, as the results presented herein show that the replacement of the C-terminus of D~2~R with that of D~3~R did not affect the interaction with β-arrestin2.

The roles of the N-terminal regions of rhodopsin family GP-CRs have been difficult to study owing to technical limitations such as challenges in getting three-dimensional information from their crystal structures ([@b5-bt-24-517]). Additionally, it is unclear how the N-terminus of D~2~R, which is located extracellularly, affects the interaction between D~2~R and β-arrestin2, which presumably occurs through intracellular regions of D~2~R. It could be speculated that shortening the N-terminus alters the overall conformation of D~2~R, such that potential strains that prevent the constitutive interaction between D~2~R and β-arrestin2 are relieved.

In a previous study, it was reported that the second and third intracellular loops of GPCRs are involved in the translocation of β-arrestins ([@b11-bt-24-517]). In this previous study, a β-arrestin translocation assay was conducted in the presence of exogenous GRK2, which potentiates the translocation of β-arrestins. Since over-expression of GRK2 potentiates the translocation of β-arrestins, there is possibility that roles of each loop in recruiting cytosolic β-arrestin2 toward plasma membrane could be over-estimated. In the current study, experiments were conducted under endogenous conditions, and we could determine the roles of each loop in agonist-induced β-arrestin2 translocation more precisely.

In conclusion, we showed that both the N-terminus and the C-terminal tail exert negative effects on the interaction between D~2~R and β-arrestin2. Though further studies are needed to understand completely the molecular details involved this process, the results presented herein may provide clues for elucidating the functional roles of the N- and C-termini of D~2~R in the interaction with β-arrestin2.
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![Comparison between D~2~R and D~3~R in agonist-induced β-arrestin translocation. (A) Visualization of β-arrestin2-GFP translo-cation in response to agonistic stimulation of D~2~R or D~3~R in HEK-293 cells. Cells stably expressing D~2~R or D~3~R (2.7 and 3.5 pmol/mg protein, respectively) were transfected with 2 μg β-arrestin2-GFP per 100 mm culture dish. Cells were stimulated with 10 μM DA for 5 min. Receptor expression levels were determined by \[^3^H\]-spiperone binding at saturating concentrations (3 nM). (B) Schematic diagram of D~2~R and D~3~R chimeric receptors. Detailed information about these constructs is described in previous studies ([@b17-bt-24-517]; [@b18-bt-24-517]).](bt-24-517f1){#f1-bt-24-517}

![Evaluation of β-arrestin2-GFP translocation after agonist activation of D~2~R, D~3~R, or D~2~R and D~3~R chimeric receptors. HEK-293 cells expressing D~2~R (2.3 pmol/mg of protein), D~3~R (3.7 pmol/mg of protein), or D~2~R and D~3~R chimeric receptors (between 2.0 and 3.5 pmol/mg protein) were transfected with 1 μg of β-arrestin2-GFP. Cells were stimulated with 10 μM DA for 5 min and viewed on a Zeiss laser scanning confocal microscope.](bt-24-517f2){#f2-bt-24-517}

![Role of the N-terminal region of D~2~R in the interaction with β-arrestin2. (A) Alignment of the amino acid sequences within the N-terminal regions of D~2~R. The numbers represent the position of the amino acid residues starting from Met^1^. Vertical arrows show the positions at which deletions were made. Squares represent consensus N-linked glycosylation sites. (B) Effects of shortening the N-terminal region on the interaction between D~2~R and β-arrestin2. HEK-293 cells were transfected with 0.8 μg of Flag-tagged D~2~R and 8 μg Flag-D~2~R-Δ(2--22) in pCMV5 per 100 mm culture dishes. Cells were treated with 10 μM DA for 5 min. Cell lysates were immunoprecipitated with Flag beads, and analyzed by an immunoblot assay with antibodies against β-arrestin2 or Flag. Cell lysates were immunoblotted with antibodies against β-arrestin2. Data represent results from three independent experiments with similar outcomes.](bt-24-517f3){#f3-bt-24-517}

![Role of the C-terminal tail of D~2~R in the interaction with β-arrestin2. (A) Alignment of the amino acid sequences within the C-terminal tail of D~2~R and D~3~R. The numbers represent the position of the amino acid residues starting from Met^1^. (B) Effects of replacing the C-terminus of D~2~R with that of D~3~R on the interaction with β-arrestin2. HEK-293 cells were transfected with Flag-D~2~R or Flag-D~2~R-D~3~C in pCMV5 together with β-arrestin2 in pCMV5. Cells were treated with 10 μM DA for 5 min. Immunoprecipitates were analyzed by an immunoblot assay with antibodies against β-arrestin2 or Flag. Cell lysates were immunoblotted with antibodies against β-arrestin2. Data represent results from three independent experiments with similar outcomes. (C) Effects of deletion of the C-terminus of D~2~R on the interaction with β-arrestin2. HEK-293 cells were transfected with Flag-D~2~R or Flag-CTX-D~2~R in pCMV5 together with β-arrestin2 in pCMV5. Cells were treated with 10 mM DA for 5 min. Immunoprecipitates were analyzed by an immunoblot assay with antibodies against β-arrestin2 or Flag. Cell lysates were immunoblotted with antibodies against β-arrestin2. Data represent results from three independent experiments with similar outcomes.](bt-24-517f4){#f4-bt-24-517}
